The FIELD trial: definitive evidence for CHD prevention in diabetes - 10/2004
FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) is a double-blind placebo-controlled trial for the prevention of coronary heart disease (CHD) in people with type 2 diabetes. This trial is being conducted in Australia, New Zealand, and Finland. A feature of the study is that due to its broad entry criteria, the results could be generalised to a population of typical patients with diabetes consulting general practitioners. The trial began recruiting patients in early 1998, and its five-year follow-up will be completed during 2005.
Themes : Metabolic Syndrome and Diabetes (Including Glucose-Insulin Homeostasis)
Author(s) :
Anthony C. KEECH
